Save up -80% on Imiglucerase
|Note: this is a drug discount program, not an insurance plan.|
|RX BIN: 015558||RX PCN: HT||Group ID: DDN6600||Card Holder ID: DDN6600|
|Pharmacists and Patients support.|
2019 Price of Cerezyme
|$1,633.98||1 vial/400 units|
|Price with discount in nearest pharmacy. Price may vary.|
We offer free Cerezyme coupons and discounts that may help you save up to 80% off the retail price in your local pharmacy. Just print your coupon! It’s ready to use and never expire. Present your manufacturer copay card in most local pharmacies to get a discount on Imiglucerase every time. What are you waiting for? Claim your prescription drug card now!
Get your Prescription
It’s safe and free
Buy drugs in pharmacy
Save money each time
Imiglucerase volume of distribution
The volume of distribution corrected for weight ranged from 0.09 to 0.15 l/kg (mean ± S.D 0.12 ± 0.02 l/kg). These variables do not appear to be influenced by dose or duration of infusion, however, only 1 or 2 patients were studied at each dose level and infusion rate.
Discount Cards 16,000+
Clients Benefit 29%
Total savings $4,735,080
What is Imiglucerase
Human Beta-glucocerebrosidase or Beta-D-glucosyl-N-acylsphingosine glucohydrolase E.C. 126.96.36.199. 497 residue protein with N-linked carbohydrates, MW=59.3 kD. Alglucerase is prepared by modification of the oligosaccharide chains of human Beta-glucocerebrosidase. The modification alters the sugar residues at the non-reducing ends of the oligosaccharide chains of the glycoprotein so that they are predominantly terminated with mannose residues
Imiglucerase mechanism of action
Imiglucerase catalyzes the hydrolysis of the glycolipid, glucocerebroside, to glucose and ceramide as part of the normal degradation pathway for membrane lipids.
Dosage forms of Imiglucerase
|Injection, powder, lyophilized, for solution||intravenous||40 U/mL|
|Powder for solution||intravenous||200 unit|
|Powder for solution||intravenous||400 unit|
Genzyme Canada A Division Of Sanofi Aventis Canada Inc
Humans and other mammals
Indication of Imiglucerase
For the treatment of Gaucher’s disease (deficiency in glucocerebrosidase)
Toxicity of Imiglucerase
In neuronopathic variants of Gaucher disease, profound failure of lysosomal sphingolipid breakdown leads to the accumulation of toxic macromolecules that originate from the rapid turnover of membrane gangliosides in neural cells. Occasional Gaucher cells are found in the Virchow-Robin spaces and sporadically within deep layers of the cerebral cortex and cerebellum.
RX24 Drugs Disclaimer: consult your healthcare provider before buying a Imiglucerase on prescription or using an RX manufacturer savings coupon. Content on this page is provided for informational purposes only. Any use of this information is at your own risk.